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Estimation of Genetic Correlation via Linkage
Disequilibrium Score Regression
and Genomic Restricted Maximum Likelihood
Guiyan Ni,1,2 Gerhard Moser,1,2 Schizophrenia Working Group of the Psychiatric Genomics
Consortium, Naomi R. Wray,3,4 and S. Hong Lee1,2,4,*
Genetic correlation is a key population parameter that describes the shared genetic architecture of complex traits and diseases. It can
be estimated by current state-of-art methods, i.e., linkage disequilibrium score regression (LDSC) and genomic restricted maximum likeli-
hood (GREML). Themassively reduced computing burden of LDSC compared to GREMLmakes it an attractive tool, although the accuracy
(i.e., magnitude of standard errors) of LDSC estimates has not been thoroughly studied. In simulation, we show that the accuracy of
GREML is generally higher than that of LDSC. When there is genetic heterogeneity between the actual sample and reference data
from which LD scores are estimated, the accuracy of LDSC decreases further. In real data analyses estimating the genetic correlation
between schizophrenia (SCZ) and bodymass index, we show that GREML estimates based on150,000 individuals give a higher accuracy
than LDSC estimates based on400,000 individuals (from combinedmeta-data). A GREML genomic partitioning analysis reveals that the
genetic correlation between SCZ and height is significantly negative for regulatory regions, which whole genome or LDSC approach has
less power to detect. We conclude that LDSC estimates should be carefully interpreted as there can be uncertainty about homogeneity
among combinedmeta-datasets.We suggest that any interesting findings frommassive LDSC analysis for a large number of complex traits
should be followed up, where possible, with more detailed analyses with GREML methods, even if sample sizes are lesser.Genetic correlation is a key population parameter that de-
scribes the shared genetic architecture of complex
traits and diseases.1–3 The genetic correlation is the additive
genetic covariance between two traits scaled by the square
root of the product of the genetic variance for each trait
(i.e., the geometric mean of the trait variances). The sign
of the correlation shows the direction of sharing, and
the parameter definition is based on genetic variants
across the allelic spectrum. Methods to estimate genetic
correlation based on genetic covariance structure are well
established for both quantitative and disease traits, e.g.,
(restricted) maximum likelihood for linear mixed models
(LMM).4–6 Genetic covariance structure can be derived
from phenotypic records using pedigree information in
twin or family-based designs.7 Recently, genome-wide
single-nucleotide polymorphism (SNP) data have been
used to construct a genomic relationship matrix for
the genetic covariance structure in LMM that captures the
contribution of causal variants that are in linkage disequilib-
rium (LD) with the genotyped SNPs.4,8,9 Such estimates
assume that the genetic correlation estimated from
common SNPs is representative of the parameter that
depends on all genetic variants; this seems like a reasonable
assumption.
In contrast to the genomic restricted maximum likeli-
hood (GREML) approach, a linkage disequilibrium score
regression (LDSC)10,11 method does not require individ-
ual-level genotype data but instead uses GWAS summary
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 2018 American Society of Human Genetics.their LD scores. The LD score of a SNP is the sum of LD
r2 measured with all other SNPs and can be calculated in
a reference sample of the same ethnicity when individual
genotype data are not available for the GWAS sample, un-
der the assumption that the GWAS sample has been drawn
from the same ethnic population as the reference sample
used to calculate the LD scores. The method exploits the
relationship between association test statistic and LD score
expected under polygenicity. Because of this simplicity,
and the massively reduced computing burden in terms of
memory and time, it is feasible for LDSC to be applied to
a large number of multiple traits, e.g., Bulik-Sullivan
et al.,11 Zheng et al.,12 Finucane et al.13
Given the attractiveness of LDSC for a massive analysis
of many sets of GWAS summary statistics, it has been
widely used in the community. However, genetic correla-
tions estimated by LDSC are often reported without
caution although the approach is known to be less accu-
rate, compared to GREML.11 In fact, the accuracies of
LDSC estimates have not been thoroughly studied.
In this report, we compare both the bias (difference be-
tween the simulated true value and estimated value) and
accuracy (magnitude of the standard error of an estimate
[SE]) between GREML and LDSC for estimation of genetic
correlation. We find that both methods show little evi-
dence of bias. However, LDSC is less accurate as reported
in Bulik Sullivan et al.,11 with SE at least more than 1.5-
fold higher than that of GREML regardless of the number
of samples in data used to estimate the genetic correlation.m Institute of Health Research, University of South Australia, Adelaide, SA
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Figure 1. The Ratio of SE of LDSC
Estimate to that of GREML Estimate
using Simulated Phenotypes Based on UK
Biobank Genotypes
Bars are 95% CI based on 100 replicates.
The unit for the number of SNPs is
thousands. This result was based on 858K
SNPs (after QC) and 10,000 individuals
that were randomly selected from UK
Biobank. SNPs in each bin were randomly
drawn from the 858K SNPs independently.
The number of causal SNPs was 10,000 that
were randomly selected in each bin. The
true simulated value for the genetic correla-
tion was 0.6 and that for the heritability
was 0.5 for both traits. Overlap (0%, 10%,
and 20%) stands for the percentage of over-
lapping individuals in the first and second
traits.When decreasing the number of SNPs, the accuracy
of LDSC decreases further. When increasing the degree of
genetic heterogeneity between the actual sample and refer-
ence data from which LD scores are estimated, the SE of
LDSC estimates are up to 3-fold larger than those of the
GREML estimates. We also show that GREML is more accu-
rate in genomic partitioning analyses over LDSC or strati-
fied LDSC (sLDSC). In genomic partitioning analyses, the
genetic parameters are estimated for genomic subsets
defined by user-specified annotations. In analyses of real
data, we show that GREML is more accurate and powerful,
e.g., GREML estimates based on 150,000 individuals give
a higher accuracy than LDSC estimates based on 400,000
individuals in estimating genetic correlation between
schizophrenia (SCZ) and body mass index (BMI) (0.136
[SE ¼ 0.017] and p value ¼ 4.54E15 for GREML versus
0.087 [SE ¼ 0.019] and p value ¼ 4.91E06 for LDSC).
In these analyses, the GREML estimate is based on UK sam-
ple only whereas the LDSC estimate is based on combined
meta-datasets among which there is uncertainty about1186 The American Journal of Human Genetics 102, 1185–1194, June 7, 2018homogeneity. Furthermore, a GREML
genomic partitioning analysis reveals
that the genetic correlation between
SCZ and height is significantly nega-
tive for regulatory regions, which is
less obvious by LDSC when using
both whole-genome and partitioned
estimates of genetic correlation.
In the main methods, we
used GREML14,15 and LDSC10,11 to
compare their estimates of genetic
correlation using simulated as well as
real data. Simulations were based on
UK Biobank imputed genotype data
(UKBB16) after stringent quality
control (QC) (see Supplemental
Methods). We calculated a ratio of
empirical SE and its 95% confidence
interval (CI) to assess the accuracy ofthe methods for each set of simulated data. The 95% CIs
of SE were estimated based on the delta method.17
When estimating genetic correlation using simulated phe-
notypes based on UKBB genotype data, we found that the
estimates were unbiased for both GREML and LDSC
(Figure S1), but the SE of GREML was at least 1.5 times
smaller than that of LDSC (Figure 1). The ratio of the
empirical SE from LDSC to GREML was increased up to
3.5-fold when using a smaller number of SNPs (Figure 1).
All values of the ratio were significantly different from 1.
It is notable that the SE of GREML estimates showed
almost no difference across different numbers of SNPs
whereas that of LDSC estimates gradually increased with
a smaller number of SNPs (Figure S2). The ratio was
invariant to sample size (Figure S3). As expected, when us-
ing the intercept constrained to zero, LDSC estimates were
substantially biased when there were overlapping samples
(Figure S4). We also explored alternative genetic architec-
tures (Figure S5), which consistently showed that GREML
gives a smaller SE than LDSC in any scenario.
Table 1. Correlation between LD Scores Estimated Based on the
HapMap3 SNPs using the 1KG CEU Reference Sample and that from
Different Target Populations
Correlation Nr.SNPs
UKBBa 0.946 858,991
UKBBrb 0.720 123,615c
WTCCC2 0.899 421,035c
GERA 0.661 238,089c
aUKBB was imputed to the combined data of the 1KG reference and
UK10K data.
bUKBBr was based on the raw genotype data of UK Biobank data.
cThe number of SNPs reduced further from the set of the QCed SNPs because
of using only SNPs matched with the HapMap3 SNPs used in calculating
LD scores.
Table 2. The Ratio of SE of LDSC Estimate to That of GREML
Estimate using Simulated Phenotypes Based on UKBB, WTCCC2,
GERA, and UKBBr Genotypes in the Scenarios without Overlapping
Individuals
800k 400k 200k 100k
UKBB 1.60 (0.15) 1.70 (0.18) 1.85 (0.25) 2.04 (0.33)
WTCCC2 NA 2.15 (0.31) 2.35 (0.43) 2.68 (0.61)
GERA NA NA 2.87 (0.56) 3.31 (1.17)
UKBBr NA NA NA 3.74 (0.79)To explore the stability of the accuracy for both
methods, we used two additional genotype datasets
without imputation, Wellcome Trust Case Control
Consortium 2 (WTCCC218–21) and genetic epidemiology
research on adult health and aging cohort (GERA22,23),
which are publicly available (see Supplemental Methods
for detailed data descriptions). We also used UKBB raw
(non-imputed) genotype data (UKBBr). We calculated the
correlation between the LD scores for the HapMap3 SNPs
estimated based on the 1KG CEU reference sample (see
Web Resources) and those based on in-sample genotype
data, i.e., UKBB, WTCCC2, GERA, and UKBBr dataset
(Table 1). We found that the WTCCC2, GERA, and UKBBr
(raw) genotypes were less similar to the 1KG reference ge-
notypes, compared to the UKBB (imputed) genotypes
(noting that UKBB samples had been imputed to the com-
bined data of 1KG reference and UK10K data). Table 2
shows that the SE ratio of LDSC estimate to GREML esti-
mate was higher for WTCCC2, GERA, and UKBBr than
that for UKBB. Figure 2 shows that the accuracy of GREML
was consistent across different datasets, whereas that of
LDSC was decreased for WTCCC2, GERA, or UKBBr,
compared to UKBB dataset. This was probably due to
higher (or lower) correlation between LD scores based on
the 1KG reference and the in-sample genotype datasets
(Table 1) which might positively or (negatively) affect the
accuracy of LDSC estimates. For WTCCC2, GERA, and
UKBBr data, the SE ratio of LDSC to GREML based on
different number of individuals is shown in Figures S6–S8.
Genome partitioning analyses are an emerging tool to
estimate the genetic variance and covariance explained
by functional categories (e.g., DNase I hypersensitive sites
[DHS] and non-DHS24). Currently, genomic partitioning
analyses focus on SNP-heritability enrichment analyses,
formally testing for enrichment of signal compared to
the expectation that the estimates are proportional to the
number of SNPs allocated to each annotation. Considering
genomic partitioning in cross-disorder analyses is a natural
extension to identify regions where genetic correlations
between disorders are highest and lowest. Here, we as-
sessed the performance of the methods in the context of
genome partitioning analyses using simulated phenotypesThe Americabased on UKBB genotype data. A better LDSC approach to
estimate genetic correlation for each category might be
sLDSC, stratifying by genomic annotation; however, this
method is currently under development (i.e., there is soft-
ware [see Web Resources], but there is no published docu-
ment or paper verifying the method). Nonetheless, since
the sLDSC is available to the research community, we
applied both LDSC and sLDSC to estimate partitioned ge-
netic correlations for the simulated data (Supplemental
Methods). For genome partitioning analyses, we showed
that LDSC estimates of genetic correlation were biased
whether using LD scores estimated from the 1KG reference
or in-sample data (UKBB) while GREML estimates gave
unbiased estimates for each functional category (Figure 3).
sLDSC estimates were unbiased only when using LD scores
from the in-sample data, and their SEs are relatively larger
than those of GREML or LDSC (Figure 3). This was prob-
ably due to the fact that the different distribution of causal
variants and their effects between DHS and non-DHS
regions were better captured by an explicit covariance
structure fitted in GREML. We also applied the methods
to a range of simulation scenarios and found similar results
in that GREML performed better than LDSC or sLDSC
(Figure S9 and Table S1), which was consistent with the
previous results (Figures 1 and 2). It is notable that in a
deliberately severe scenario (e.g., causal variants are simu-
lated only within few kb of a boundary), GREML could
give biased estimation of genetic correlation.13,24
While focusing on the accuracy of genetic correlation es-
timates, there is an important implication for the bias in
SNP-heritability estimates for both GREML and LDSC
(Figure S10). When using the WTCCC2, GERA, and UKBBr
data, which were less similar to the 1KG reference geno-
types, compared to the UKBB data, LDSC estimates were
substantially biased whereas GREML estimates were close
to the true value in estimation of SNP heritability
(Figure S10). However, this result is well known and
LDSC was not recommended for SNP heritability by the
original authors,10 but rather only for relative enrichment
analysis. Despite this, LDSC is widely used for SNP-herita-
bility estimation (because it is quick and simple). Thus, for
completeness we include analyses for different scenarios to
quantify the properties of the methods. When reducing
the number of SNPs, estimated SNP heritabilities from
LDSC were consistently unbiased; however, those from
GREML were proportionally underestimated (Figure S11).n Journal of Human Genetics 102, 1185–1194, June 7, 2018 1187
Figure 2. Estimated Genetic Correlation
with GREML and LDSC (without Constrain
to the Intercept) Based on Different
Genetic Datasets
Simulation was based on 10,000 individ-
uals that were randomly selected from
UKBB, WTCCC2, GERA, and UKBBr (the
raw genotype of UKBB), with 858K, 432K,
239K, and 124K SNPs, respectively. Bars
are 95%CI based on 100 replicates. Overlap
(0%, 10%, and 20%) stands for the percent-
age of overlapping individuals in the first
and second traits. The gray dashed line
stands for the true simulated genetic corre-
lation 0.6.When using non-HapMap3 SNPs, LDSC estimates were
consistently biased (Figure S12) and less accurate,
compared to GREML estimates (Figures S13 and S14),
which probably explains why LDSC is implemented using
only HapMap3 SNPs. Although the genetic correlation is
robust to such biasedness,4,11 SNP heritability itself should
be carefully interpreted for both GREML and LDSC. We
also noted that LDSC and sLDSC estimates for SNP herita-
bility were biased in the genome partitioning analysis
(Figure S15) although the estimated enrichment was close
to the true value when using sLDSC and in-sample LD
scores (Figure S15).
We used real phenotype and individual genotype data
from the Psychiatric Genomics Consortium (PGC) and
UKBB to estimate genetic variance and covariance between
SCZ and BMI using LDSC and GREML (Table 3 and
Figure S16). We also used publicly available GWAS sum-1188 The American Journal of Human Genetics 102, 1185–1194, June 7, 2018mary statistics for LDSC to see how
much the SE of estimates could be
reduced by increasing the number of
samples and number of SNPs. For
real data analyses, we obtained theo-
retical SE to assess the accuracy of
the methods. GREML and LDSC esti-
mates for the SNP heritability were
0.192 (SE 0.004) and 0.280 (SE 0.016)
for SCZ and 0.184 (SE 0.004)
and 0.255 (SE 0.014) for BMI. The
notable difference between GREML
and LDSC was probably because of a
relatively small number of SNPs
(500K) that might result in underesti-
mated GREML SNP heritability (see
Figure S11). This is one of the caveats
of using GREML with real data that
usually comprise multiple cohorts
genotyped on different platforms,
such that, even with imputation, the
overlapping set of SNPs imputed
with high confidence may be limited.
The estimated genetic correlation for
GREML and LDSC was 0.136
(SE 0.017) and 0.173 (SE 0.031). This indicated that the
GREML estimate was 3.5 and 1.8 times more precise than
LDSC estimates for the SNP heritability and genetic corre-
lation, respectively. For LDSC, we also considered using
additional GWAS summary statistics from publicly avail-
able resources.25,26 The sample sizes used for additional
LDSC analyses (LDSC-meta) are summarized in Table 3.
The estimated SNP heritability was 0.259 (SE 0.019) for
SCZ and 0.121 (SE 0.007) for BMI, and the estimated ge-
netic correlation was 0.087 (SE 0.019). Although sample
size was increased 2.7-fold, the SE of LDSC estimate was
not smaller than that for GREML estimate (SE ¼ 0.017
versus 0.019, and p value ¼ 4.54E15 versus 4.91E06
for GREML versus LDSC) (Table 3). It should be noted
that GREML estimates used a homogeneous population
(within UK and after stringent QC excluding population
outliers) whereas LDSC-meta1 and -meta2 were based on
Figure 3. Estimated Genetic Correlation
of Simulated Data Based on a Genomic
Partitioning Model
Simulation was based on 10,000 individuals
that were randomly selected from UKBB
with 858K SNP. Based on Gusev et al.,24 the
858K SNPs across the genomewere stratified
as two categories: DHS (194K SNPs with
2,268 causal SNPs) and non-DHS (664K
SNPs with 7,732 causal SNPs). The genetic
correlation for the simulatedphenotypesbe-
tween the first and second traits was 0.6 and
0.6 in DHS and non-DHS region, respec-
tively. Bars are 95% CI based on 100 repli-
cates. LDSC-CEU: Using LD-scores esti-
mated from 1KG reference data. LDSC-
OWN: Using LD-scores estimated from
UKBB. sLDSC-CEU: Using stratified LD-
scores estimated from 1KG reference data.
sLDSC-OWN:Using stratified LD-scores esti-
mated from UKBB. The presented results
were based on 0% overlapping samples be-
tween the first and second traits and those
based on other scenarios (e.g., 10% and
20%) are presented in Table S1.combined meta-datasets consisting of 80 different
studies for which there is much more uncertainty about
homogeneity than when using a single study cohort
such as UKBB. The large difference of the estimates
between LDSC and LDSC-meta1 (or -meta2) was probably
due to the fact that heterogeneity among the 80 different
studies resulted in underestimation of the common
genetic variance and covariance, and that the difference
of LD scores between the target and 1KG reference data
would bias the LDSC estimates as shown in Figure S10.
We also analyzed height data27 and found a similar
pattern in that GREML estimates were more accurate
than LDSC estimates whether using the same data or using
additional GWAS summary statistics for LDSC (Figure S17
and Table S2).
In the real data analyses, we carried out a functional
category analysis partitioning the genome into regulatory,
DHS, intronic, and intergenic regions using GREML
(Figure 4 for SCZ/height and Figure S18 for SCZ/BMI).
For SCZ and height, the genetic correlation for the regula-
tory region was negative and significantly different from 0
(p value ¼ 0.0028; Figure 4). We also compared the results
with the LDSC genetic correlation estimation (Figures S19The American Journal of Human Geand S20), and show that the estimates
were similar between LDSC and
GREML. However, GREML had a
lower p value (0.0028 in Figure 4)
than LDSC using LD scores from the
1KG reference data (p value ¼ 0.04)
or using LD scores from the in-sample
data (p value ¼ 0.007). We note that
current sLDSC software does not pro-
vide a SE of estimated partitioned
genetic correlation for each category;therefore, we did not attempt using the software for
the real data analysis. For SNP-heritability estimation,
the SE of the estimate for each category was much lower
for GREML than sLDSC, ranging from 2.2- to 5.9-fold
(Table S3).
LDSC and GREML are the methods that have been
widely used in estimating genetic correlation, shedding
light on the shared genetic architecture of complex traits,
based on genome-wide SNPs. Two critical parameters for
assessing methods are bias (whether the estimates over
replicated analyses differ from the true value) and accuracy
(reflected by the standard error of the estimate). Although
the property of the accuracy of GREML has been thor-
oughly studied and tested,29,30 that of LDSC has not
been sufficiently investigated. In this report, we compare
the accuracy of GREML and LDSC estimates based on
various scenarios using simulated as well as real datasets,
and draw simple but useful guidelines (Box 1).
Both GREML and LDSC are methods that aim to esti-
mate the same genetic correlation parameter based on
genetic variants across the allelic spectrum as defined
earlier and the definition is invariant across the methods.
The estimates from both GREML and LDSC are valid if allnetics 102, 1185–1194, June 7, 2018 1189
Table 3. Heritability and Genetic Correlation Based on Different Datasets
Method #SNPs Data
# Individuals h2 BMI h2 SCZ (Liability Scale) Genetic Correlation
Mean SD Estimate SE Estimate SE Estimate SE p
GREML 518,992 UKBBþSCZ(qced) 152,961 – 0.184 3.80E03 0.192 4.39E03 0.136 1.74E02 4.54E15
LDSC 516,519 UKBBþSCZ(qced) 151,262 1,432.7 0.255 1.38E02 0.280 1.63E02 0.173 3.08E02 1.91E08
LDSC-meta1 477,163 UKBBþGIANTþPGCSCZ 422,499 20,226.0 0.111 8.10E03 0.259 1.28E02 0.091 2.44E02 1.95E04
LDSC-meta2 1,011,748 UKBBþGIANTþPGCSCZ 414,707 32,697.8 0.121 6.50E03 0.261 1.03E02 0.087 1.90E02 4.91E06
GREML: Analysis was based on quality controlled genetic data for BMI (from UK Biobank with 111,019 individuals and 518,992 SNPs) and schizophrenia
(from PGC with 41,630 individuals and 518,992 SNPs).
LDSC: The datasets used in LDSC were the same as in GREML.
LDSC-meta1: GWAS summary statistics for BMI were based on meta-analyzed GWAS results of UKBB individual-level genetic data (with 111,019 individuals
and 518,992 SNPs) and of GIANT (245,051 individuals and 477,163 SNPs). For SCZ, the GWAS summary statistics from the full PGC sample based on 77,096
individuals were used.
LDSC-meta2: The datasets used in LDSC-meta2 were the same as in LDSC-meta1 except the increased number of SNPs (1,011,748) with which its performance
was to check.
Mean and SD of #individuals: Due to different call rates of each SNP, number of individuals for each SNP used in GWAS were different.required assumptions are met. GREML estimates variance/
covariance components based on genetic covariance struc-
ture estimated from available (in-sample) individual geno-
types, whereas LDSC estimates variance/covariance com-
ponents based on association test statistics corrected for
LD structure inferred from the markers in the reference
panel (e.g., 1KG of the same ethnicity). The underlying
assumption is that the samples generating the GWAS
summary statistics are drawn from the same population
as the samples generating the LDSC statistics, but
here we showed that there can be LD-structure (LD-scores)
differences between in-sample and reference data, which
impacts parameter estimations (Tables 1 and 2 and
Figure S10).
The reduced computing burden of LDSC over GREML
makes it the method of choice for generating a quick over-
view of the genetic relationship between disorders
(Table S4). However, our results suggest that important
associations could be overlooked. For example, Bulik-
Sullivan et al.11 reported a negative genetic correlation be-
tween BMI and SCZ estimated by LDSC (estimate ¼
0.095, SE ¼ 0.025 with p value ¼ 1.75E4), which was
not significant after Bonferroni correction for the multiple
testing. Because of the limited power from LDSC analysis,
the shared genetic architecture between BMI and SCZ,
perhaps, has had less attention than it is due.We confirmed
the negative genetic correlation between BMI and SCZwith
a greater confidence (estimate ¼ 0.136, p value ¼
4.54E15) using GREML. A second example is in analyses
investigating the shared genetic architecture between
height and SCZ, in which epidemiological evidence points
to anegative association,31 supportedbygenetic analyses.32
However, there was no evidence of genetic correlation be-
tween height and SCZ in whole-genome level analyses of
Bulik-Sullivan et al.11 (estimate ¼ 0.002, SE ¼ 0.022). We
used a GREML genomic partitioning analysis and found a
significant negative genetic correlation between height
and SCZ for the regulatory region (Figure 4). It was noted
that the regulatory region was highly enriched for height
(estimate ¼ 0.094, p value ¼ 7.60E92 in Table S3), which1190 The American Journal of Human Genetics 102, 1185–1194, Junintuitively supports a significant genetic correlation with
SCZ for the region. As shown in Figures 3 and S15, the
GREML estimate was closer to the true values with a lower
SE than LDSC or sLDSC estimate in simulated data. For
the real data analyses (Table S3), GREML hadmore accurate
SNP-heritability estimates (lower SE) than sLDSC. More-
over, the sum of each category matched well with the esti-
mate of the whole genome for GREML whereas this was
not the case for sLDSC (Tables S3).
Here we focused on genetic correlation estimates and
did not consider a number of alternative approaches
that have been explored in detail for estimation of SNP
heritability, e.g., LDAK approach,33 weighted genomic
relationship matrix,34 MAF stratified,29 and LD-MAF strat-
ified approaches.35 It was beyond the scope of our study to
assess whether biasedness and accuracy can be improved
with these methods, although a general observation is
that biases in SNP-heritability estimation can ‘‘cancel’’ in
estimates of genetic correlations, as biases impact both
the numerator and denominator of the genetic correlation
quotient.4,11 We note that while under review, two new
methods to estimate stratified genetic correlations via
GWAS summary statistics36,37 have been published as
alternatives to sLDSC. Those approaches also need external
reference samples to infer LD structure in the actual sam-
ple, implying the same problem as for LDSC (4 and 5 in
Box 1). However, to partially address this problem, one
method36 achieves smaller standard errors than sLDSC
through a block diagonalization of the LD matrix. A
further study is needed to make explicit comparisons
with GREML.
In conclusion, LDSC may be the best tool for a massive
analysis of multiple sets of GWAS summary statistics in
estimating genetic correlation between complex traits,
because of its low computing burden and because
summary statistics may be available for much larger
sample sizes than those with individual genotype data.
However, LDSC estimates should be carefully interpreted,
considering the summary points (Box 1). Any interesting
findings from LDSC analyses should be followed up, wheree 7, 2018
Figure 4. Genetic Correlation between SCZ and Height and
Heritability Based on SNPs in Partitioned Genomic Regions Esti-
mated with GREML
A joint model was applied by fitting four genomic relationship
matrices simultaneously, each estimated based on the set of
SNPs belong to each of the functional categories (regulatory,
intron, intergene, and DHS). The bars are standard errors.
p value for the estimate significantly different from 0 was
0.0028, 0.52, 0.91, and 0.67 for regulatory, intronic, intergenic,
and DHS region, respectively.possible, with more detailed analyses using individual
genotype data and with GREML methods, even though
sample sizes with individual genotype data may be smaller.Supplemental Data
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Box 1. Summary Points
1. GREML and LDSC can both provide unbiased estimates of the genetic correlation between two traits. GREML
requires individual-level genotype data, while LDSC requires only association summary statistics and LD scores
per SNP. If LD scores have been calculated from the same sample as the association statistics, then GREML and
LDSC provide similar estimates of the genetic correlation. However, in practice LD scores are estimated from
external reference samples of the same broad ethnicity, which can lead to bias in the estimates (Figures S21
and S22). As a rule of thumb, when LDSC and GREML estimates are dissimilar, we recommend reporting the
estimate with a lower SE. The theoretical SE of the estimates is a reliable indicator to determine the better
estimator, which agrees well with the empirical SE (from simulation replicates) (Figure S23).
2. When combining multiple data sets to estimate genetic correlations between multiple traits, it is possible, in
practice, that the number of SNPs remaining after QC is relatively small. When the number of available
SNPs is small, the SE of LDSC estimates for genetic correlation can be increased relatively more, compared to
that of GREML estimates (Figure S2).
3. SNP heritability has a different property, compared to genetic correlation since the latter is robust to biased
estimation of genetic variance and covariance (presumably the biases occur in the numerator and denominator
and hence approximately cancel out).4,11 Especially when using a small number of SNPs (<500K) for GREML or
when using multiple meta-data sets for LDSC, estimated SNP heritability itself should be reported with caution
as both methods can give biased estimates.
4. When using a study cohort, it is desirable to measure heterogeneity between the cohort and 1KG reference data
(e.g., measuring the correlation between LD scores estimated based on the cohort and 1KG reference data as in
Table 1). If the correlation is not close to 1, LDSC estimates should be carefully interpreted. We recommend that
when GWAS summary statistics are provided, cohort-specific LD scores are provided also. It is also warranted
that an optimal approach to meta-analyze LD scores across multiple cohorts should be developed to improve
LDSC performance.28
5. When using extensive metadata that possibly include heterogeneous sources, there are two problems. Firstly,
the LD scores estimated from reference samples such 1KG reference may be a poor representation of the LD
scores of the heterogeneous metadata, such that the accuracy of LDSC decreases. Second, the distribution of
causal variants and pleiotropic effects may be different between heterogeneous sources such that the estimates
can be biased (capturing only common effects between heterogeneous sources). This implies that LDSC
estimates should be reported with caution when using extensive metadata sets (Table 3).
6. One of advantages of having access to individual-level genotype data comes when more detailed analyses are
required, such as genomic partitioning analyses. As shown in Figure 4, a GREML genomic partitioning analysis
reveals a significant negative genetic correlation between SCZ and height for the regulatory region, which
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